The Dividend Yield as of November 2024 (TTM) for Protagonist Therapeutics, Inc. (PTGX) is 0%

According to Protagonist Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Protagonist Therapeutics, Inc. (PTGX) Historical Dividend Yield (quarterly & annually)

How has PTGX Dividend Yield performed in the past?

The mean historical Dividend Yield of Protagonist Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), PTGX's Dividend Yield was at its highest in in the March 2015 quarter at 0%. The Dividend Yield was at its lowest in in the March 2015 quarter at 0%.

Protagonist Therapeutics, Inc. (PTGX) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Protagonist Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Protagonist Therapeutics, Inc. (PTGX) Average Dividend Yield

How has PTGX Dividend Yield performed in the past?

The current Dividend Yield of Protagonist Therapeutics, Inc. (PTGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Protagonist Therapeutics, Inc. (PTGX) Dividend Yield vs. Peers

How is PTGX’s Dividend Yield compared to its peers?

Protagonist Therapeutics, Inc.’s Dividend Yield is less than Revolution Medicines, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Avidity Biosciences, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Kura Oncology, Inc. (0%), less than Merus N.V. (0%), less than Replimune Group, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Arvinas, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than IDEAYA Biosciences, Inc. (0%), less than Verona Pharma plc (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than HOOKIPA Pharma Inc. (0%),

Build a custom stock screener for Protagonist Therapeutics, Inc. (PTGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protagonist Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Protagonist Therapeutics, Inc. (PTGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Protagonist Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.